Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

HM Lokhorst; Pieter Sonneveld; Jan Cornelissen; M van Marwijk Kooy; HK Nieuwenhuis; MHJ van Oers; DJ Richel; LF Verdonck; PW Wijermans

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

HM Lokhorst, Pieter Sonneveld, Jan Cornelissen, M van Marwijk Kooy, HK Nieuwenhuis, MHJ van Oers, DJ Richel, LF Verdonck, PW Wijermans

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	317-322
Number of pages	6
Journal	Bone Marrow Transplantation
Volume	23
Publication status	Published - 1999

Cite this

Lokhorst, HM., Sonneveld, P., Cornelissen, J., van Marwijk Kooy, M., Nieuwenhuis, HK., van Oers, MHJ., Richel, DJ., Verdonck, LF., & Wijermans, PW. (1999). Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. Bone Marrow Transplantation, 23, 317-322.

Lokhorst, HM ; Sonneveld, Pieter ; Cornelissen, Jan ; van Marwijk Kooy, M ; Nieuwenhuis, HK ; van Oers, MHJ ; Richel, DJ ; Verdonck, LF ; Wijermans, PW. / Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. In: Bone Marrow Transplantation. 1999 ; Vol. 23. pp. 317-322.

@article{4ae71817350d4081913017fb32b64cbd,

title = "Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma",

author = "HM Lokhorst and Pieter Sonneveld and Jan Cornelissen and {van Marwijk Kooy}, M and HK Nieuwenhuis and {van Oers}, MHJ and DJ Richel and LF Verdonck and PW Wijermans",

year = "1999",

language = "Undefined/Unknown",

volume = "23",

pages = "317--322",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

}

Lokhorst, HM, Sonneveld, P , Cornelissen, J, van Marwijk Kooy, M, Nieuwenhuis, HK, van Oers, MHJ, Richel, DJ, Verdonck, LF & Wijermans, PW 1999, 'Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma', Bone Marrow Transplantation, vol. 23, pp. 317-322.

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. / Lokhorst, HM; Sonneveld, Pieter ; Cornelissen, Jan; van Marwijk Kooy, M; Nieuwenhuis, HK; van Oers, MHJ; Richel, DJ; Verdonck, LF; Wijermans, PW.

In: Bone Marrow Transplantation, Vol. 23, 1999, p. 317-322.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

AU - Lokhorst, HM

AU - Sonneveld, Pieter

AU - Cornelissen, Jan

AU - van Marwijk Kooy, M

AU - Nieuwenhuis, HK

AU - van Oers, MHJ

AU - Richel, DJ

AU - Verdonck, LF

AU - Wijermans, PW

PY - 1999

Y1 - 1999

M3 - Article

VL - 23

SP - 317

EP - 322

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -